A Complete Human Y to ask more "Why" in biology

Sep 1, 2023

Share article
Weilin Liu Senior Field Application Scientists MGI

Dr. Weilin Liu - Field Application Scientist at MGI

A Complete Human Y to ask more "Why" in biology
A Complete Human Y to ask more "Why" in biology
A Complete Human Y to ask more "Why" in biology

Though the human Y chromosome is a "tiny" guy among other chromosomes, it has been regarded as the notoriously difficult target to sequence and assemble because of its complex repeat structures including tandem repeats, long palindromes, and segmental duplications. Thus, not surprisingly, more than half of the Y chromosome has been missing from the GRCh38 reference and it remains the last riddle in human chromosome to be challenged.

A milestone study published recently in Nature by the Telomere-to-Telomere (T2T) consortium (Rhie A et al., Nature, 2023) presents the complete 62,460,029 base pair sequence of a human Y chromosome from the HG002 genome (T2T-Y) that corrects multiple errors in GRCh38-Y references and adds over 30 Mb of sequence, which are predominantly from the heterochromatic region of the Yqh-arm (Figure 1), unmasking the complete ampliconic structures of TSPY, DAZ, and RBMY, and moreover discovering 110 genes, among which 42 are predicted to be protein-coding genes from the TSPY gene family. It has been known that 9 protein-coding ampliconic gene families have expanded specifically on the Y and are expressed in testis functioning in spermatogenesis and fertility. These findings are particularly intriguing when concerning of evolution and sex determination since Y chromosome has been lost by certain non-mammalian species and this latest study could inspire us to understand how mammals follows a similar biological fate.

By combining T2T-Y with a prior assembly of the CHM13 genome, available population variation, clinical variants, and functional genomics data, the study has been mapped to produce a complete and comprehensive reference sequence for all 24 human chromosomes. Notably, both short and long read sequencing technologies have been utilized in this study to structure the entire human Y chromosome by frames and details, highlighting the potency of this “short + long” strategy in future sequencings. Long-read overcomes those complicated tandem repeat region, copy numbers and high-ploidy, short-read polishes the genomic details such as SNP and sequence variants. 

The more we dig, the more we understand those scientific mysteries, in the meanwhile arising more “Why”s to be answered in the Omic-verse of Biology.

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

GENOMEPIONEERS

PRECISION MEDICINER EVOLUTION

NEXTGENSEQUENCING

LABAUTOMATIONFUTURES

GLOBALGENOMICS

GLOBALGENOMICS

Share this article :

Share

More Science

Smart-seq3Xpress: a scalable, high-sensitivity and low-cost Single cell Full-length RNA-seq methodology.
Smart-seq3Xpress: a scalable, high-sensitivity and low-cost Single cell Full-length RNA-seq methodology.
Smart-seq3Xpress: a scalable, high-sensitivity and low-cost Single cell Full-length RNA-seq methodology.
Smart-seq3Xpress: a scalable, high-sensitivity and low-cost Single cell Full-length RNA-seq methodology.

Mar 5, 2024

Smart-seq3Xpress: a scalable, high-sensitivity and low-cost Single cell Full-length RNA-seq methodology.

Revolutionizing single-cell RNA-seq, SMART-seq3Xpress offers unparalleled sensitivity and cost-efficiency with full-length coverage.

Single-cell Spatial transcriptomics (sc-StereoSeq), opening a new era in plants and crops biology.
Single-cell Spatial transcriptomics (sc-StereoSeq), opening a new era in plants and crops biology.
Single-cell Spatial transcriptomics (sc-StereoSeq), opening a new era in plants and crops biology.
Single-cell Spatial transcriptomics (sc-StereoSeq), opening a new era in plants and crops biology.

Jan 10, 2024

Single-cell Spatial transcriptomics (sc-StereoSeq), opening a new era in plants and crops biology.

Explore how sc-StereoSeq is transforming our understanding of plant biology, from crop production to plant stress responses, marking a new era in spatial transcriptomics.

Can Next-generation Sequencing accelerate mRNA vaccine development?
Can Next-generation Sequencing accelerate mRNA vaccine development?
Can Next-generation Sequencing accelerate mRNA vaccine development?
Can Next-generation Sequencing accelerate mRNA vaccine development?

Oct 10, 2023

Can Next-generation Sequencing accelerate mRNA vaccine development?

Explore the transformative impact of Next-Generation Sequencing in mRNA vaccine development. Dive into Nobel-winning discoveries, challenges, and novel technologies like the VAX-seq workflow, enhancing vaccine production, safety, and quality analysis amidst global health crises.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.